Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - AVENUE THERAPEUTICS, INC. | tv486678_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - AVENUE THERAPEUTICS, INC. | tv486678_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - AVENUE THERAPEUTICS, INC. | tv486678_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - AVENUE THERAPEUTICS, INC. | tv486678_ex23-1.htm |
| EX-10.9 - EXHIBIT 10.9 - AVENUE THERAPEUTICS, INC. | tv486678_ex10-9.htm |
| EX-10.7 - EXHIBIT 10.7 - AVENUE THERAPEUTICS, INC. | tv486678_ex10-7.htm |
| 10-K - FORM 10-K - AVENUE THERAPEUTICS, INC. | tv486678_10k.htm |
Exhibit 32.1
Certification of
Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Lucy Lu, M.D., Chief Executive Officer of Avenue Therapeutics, Inc. (the “Company”), in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Annual Report on Form 10-K for the period ended December 31, 2017 (the “Report”) filed with the Securities and Exchange Commission:
| · | Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| · | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Lucy Lu, M.D. | |
| Lucy Lu, M.D. | |
| President and Chief Executive Officer | |
| (Principal Executive Officer) | |
| March 1, 2018 |